(NYSE: PFE) Pfizer's forecast annual revenue growth rate of 4.07% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 9.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.89%.
Pfizer's revenue in 2024 is $55,643,000,000.On average, 6 Wall Street analysts forecast PFE's revenue for 2024 to be $347,778,749,812,869, with the lowest PFE revenue forecast at $346,343,132,285,270, and the highest PFE revenue forecast at $349,896,841,427,196. On average, 6 Wall Street analysts forecast PFE's revenue for 2025 to be $353,802,117,997,588, with the lowest PFE revenue forecast at $348,157,891,379,516, and the highest PFE revenue forecast at $365,031,495,937,688.
In 2026, PFE is forecast to generate $354,501,705,503,409 in revenue, with the lowest revenue forecast at $348,405,412,619,912 and the highest revenue forecast at $364,328,825,749,752.